1. Introduction {#sec0005}
===============

Angiomyolipoma (AML) is a unique and rare tumour containing varying percentages of blood vessels, smooth muscle, and adipose cells \[[@bib0005]\]. These tumours generally arise in the kidneys \[[@bib0010]\], but can also affect several other organs, including the liver, albeit less frequently \[[@bib0015],[@bib0020]\]. Hepatic AML was first reported by Ishak et al. in 1976 \[[@bib0025]\], and the first case in Eastern Asia was reported in Japan by Kawarada et al. in 1983 \[[@bib0015]\]. Around 120 cases have now been reported worldwide, and the majority have been defined as benign, only a few showing marginal malignant potential \[[@bib0030],[@bib0035]\]. Despite this, invasive liver resection for potentially malignant lesions can rarely be avoided for hepatic AML because its clinical characteristics demonstrated by preoperative imaging are similar to those of malignant hepatocellular carcinoma (HCC). Generally, differential diagnosis can only be achieved postoperatively based on immunohistochemical staining of tissue sections for human melanoma black 45 (HMB-45) and melanin (Melan-A) \[[@bib0040],[@bib0045]\]. More accurate and effective imaging techniques would be highly valuable for characterization of focal solid hepatic lesions, and in fact a few case studies have reported that more informative surgical decisions can be made on the basis of magnetic resonance imaging (MRI) and angiography in this area \[[@bib0050], [@bib0055], [@bib0060]\]. Here we present a rare case of hepatic myomatous AML, which we identified preoperatively based on certain features demonstrated by MRI and angiography. The work has been reported in line with the SCARE criteria \[[@bib0065]\].

2. Presentation of case {#sec0010}
=======================

An 80-year-old woman was admitted to our institute with a feeling of abdominal distension. Abdominal ultrasound (US) revealed a large liver tumour located in the lateral segment. The patient had no history of liver disease or hepatitis and did not drink alcohol. A range of diagnostic tests and examinations were carried out to evaluate the possibility of malignancy. Hepatitis B surface antigen and anti-hepatitis C antibody were negative. Laboratory tests revealed a white blood cell count of 3000/mm^3^, haemoglobin 12.5 g/dL, platelet count 17.9 × 10^4^/mm^3^, albumin 3.2 g/dL, total bilirubin 0.5 mg/dL, and direct bilirubin 0.3 mg/dL. Serum levels of transaminase, alpha-foetoprotein (AFP) and protein induced by vitamin K absence or antagonist- 2 (PIVKA II) were within the normal ranges ([Table 1](#tbl0005){ref-type="table"}). Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging (EOB-MRI) showed a hepatic mass with early-phase hyperattenuation and portal-phase hypoattenuation with gradual wash-out in the lateral segment ([Fig. 1](#fig0005){ref-type="fig"}A and B). This was followed by a decrease of the tumour signal in the delayed phase. The hepatocyte phase showed a typical wash-out pattern and low signal, indicating a hypo-enhanced lesion, measuring 6.2 cm × 6.0 cm ([Fig. 1](#fig0005){ref-type="fig"}C and D). In addition, out-of-phase EOB-MRI revealed high intensity in the whole tumour ([Fig. 1](#fig0005){ref-type="fig"}E), with several remarkable small areas of low intensity ([Fig. 1](#fig0005){ref-type="fig"}F). This pattern indicated that, overall, the tumour contained a minimal amount of fluid but a small amount of fat, suggesting either hepatic AML or hepatocellular carcinoma including some fat components. Subsequent angiography revealed the tumour as a well circumscribed hypervascular mass ([Fig. 2](#fig0010){ref-type="fig"}A) with central vessels, and notably a drainage vein from the tumour to the inferior vena cava (IVC) ([Fig. 2](#fig0010){ref-type="fig"}B). This latter feature is known as early venous return and is specific to AML \[[@bib0070]\]. Therefore, on the basis of imaging alone, we diagnosed this tumour as AML containing a small amount of fat. However, given the large size of the tumour and the low but notable probability of malignancy \[[@bib0075]\], we decided to remove the tumour using minimally invasive surgery after obtaining informed consent from the patient. Laparoscopic resection of the lateral segment containing the tumour was performed. The light brown tumour measured 6.2 cm × 6.0 cm and had no capsule but distinct boundaries, with mild internal hemorrhage ([Fig. 3](#fig0015){ref-type="fig"}). Histologically, hematoxylin and eosin staining showed that the tumour was composed mainly of smooth muscle cells, with only small numbers of adipose cells and blood vessels ([Fig. 4](#fig0020){ref-type="fig"}). Immunohistochemical staining revealed that the tumour had no evident hepatocyte structure, but was strongly positive for HMB-45, which is the most sensitive marker of AML, and the smooth muscle cells were positive for Melan-A ([Fig. 5](#fig0025){ref-type="fig"}). Consequently, our final diagnosis was myomatous-type hepatic AML, which was the same as our preoperative diagnosis. The patient was discharged 8 days after the operation and the postoperative period was uneventful. She is currently doing well after 3 years of follow-up.Table 1Laboratory data.Table 1VariablesFiguresHBsAgnegativeHCVAbnegativeAST (U/L)18ALT(U/L)14γ-GTP (mU/mL)166ALP (U/L)32T-Bil (mg/dL)0.5Alb (mg/dL)3.2AFP (ng/mL)3.0PIVKA II (U/mL)19[^1]Fig. 1EOB-MRI showed a hepatic mass with early-phase hyperattenuation and portal-phase hypoattenuation with gradually wash out the medium ([Fig. 1](#fig0005){ref-type="fig"}A and B). This was followed by a decreasing the tumour signal in the delayed phase. The hepatobiliary phase showed a wash-out pattern and low signal, which was hypoattenuation, measuring 6.2 cm × 6.0 cm ([Fig. 1](#fig0005){ref-type="fig"}C and D). The opposed phase of EOB-MRI revealed high intensity of whole the tumour with small low intensity inside the tumour.Fig. 1Fig. 2On angiography, the tumour was shown　as a circumscribed hypervascular mass ([Fig. 2](#fig0010){ref-type="fig"}A)　and central vessels were detected, which illustrated drainage vein from tumour to IVC ([Fig. 2](#fig0010){ref-type="fig"}B).Fig. 2Fig. 3The tumour measured 6.3 cm × 6.0 cm in　diameter, distinct boundaries, no capsule, light brown tone, solid mild accompanying bleeding inside. Histologically, the tumor was mainly composed　of smooth muscle cells and contained small amounts　of adipose cells and blood vessels.Fig. 3Fig. 4On hematoxylin-Eosin staining, the tumour was mainly composed　of smooth muscle cells and contained small amounts　of adipose cells and blood vessels.Fig. 4Fig. 5On immunohistochemical staining, the tumour was　negative for hepatocyte structure, but positive for human melanin black 45(HMB-45) and the smooth muscle cells were positive for a　melanocytic cell-specific monoclonal antibody (Melan-A).Fig. 5

3. Discussion {#sec0015}
=============

In this case study, we were able to diagnose a hepatic myomatous AML preoperatively based on both the tumour composition and the presence of early venous return, identified by MRI and angiography, respectively. AML tumours are composed of three components -- fat, smooth muscle and blood vessels -- and they can be classified into four tumour types based on the predominance of these components. The most common is the mixed or lipomatous type, in which the tumour contains more than 70% fat. The others include the angiomatous, epithelioid, and myomatous types, the latter being the type reported here and containing less than 10% fat \[[@bib0005],[@bib0030]\]. This small fat component makes it more difficult to distinguish AML from hepatocellular carcinoma, as when fat is the dominant component, some distinctive imaging features are discernible, thus increasing the possibility of a differential diagnosis. In spite of this, we were able to favour a diagnosis of AML from the EOB-MRI findings based on both the lack of a fluid component within the tumour, as identified by the in-phase image, as well as the presence of a small fat component, as identified by the out-of-phase image. These MRI results were subsequently confirmed by immunohistochemical staining, the tumour being negative for a hepatocyte marker, thus ruling out HCC, but positive for HMB-45 and the smooth muscle cells were positive for Melan-A, which is only weakly to moderately positive in epithelioid AML \[[@bib0080]\], thereby indicating that the tumour was of the myomatous type.

We therefore suggest that EOB-MRI is a valuable modality for clarifying the tumour components, thus allowing distinction between hepatic AML and HCC \[[@bib0085]\]. Moreover, AML has been shown to exhibit early intense contrast enhancement on MRI, which peaks later than that of hepatocellular carcinoma \[[@bib0090]\]. If we had compared the timing of the contrast in early-phase MRI, we might have obtained data on a further imaging feature that would have contributed to the diagnosis of AML.

Another distinctive feature identified in the tumour that led to the preoperative diagnosis was the presence of early venous return, which was identified via angiography, and has previously been reported as a typical feature of AML \[[@bib0070],[@bib0095]\]. Iwao et al. reported the presence of anomalous circulatory pathways in tissue sections from three out of four of the hepatic AML cases they studied. Specifically, there were many well-defined thick-walled vessels, such as arteries, that entered the tumour, and were directly connected within the tumour to thin-walled vessels, resembling arteriovenous fistulae. These thin-walled vessels were in turn connected directly to the hepatic vein. These histological features suggest that the rich arterial flow into the tumour is rapidly drained into the hepatic vein via arteriovenous connections within the tumour \[[@bib0095]\]. To our knowledge, however, the present case study is the first to have demonstrated both of these unique characteristic clearly, and therefore we believe that our findings would be informative for differential diagnosis of AML from other hypervascular liver tumours.

In addition to our imaging results, the laboratory data from the patient's blood sample also contributed to the preoperative diagnosis; the fact that the tumour markers we tested were all within the normal ranges made hepatocellular carcinoma unlikely. In the past, when AML tumours were considered benign, diagnosis by transdermal needle biopsy was standard, but given the potential for malignancy, an accurate diagnosis from imaging and laboratory data is desirable.

Despite the accurate preoperative diagnosis in the present case, we were unable to avoid a lateral liver segmentectomy, as the tumour occupied the entire lateral segment even though partial liver resection is sufficient for AML. In addition, despite the challenges involved in accurate preoperative diagnosis of AML, there is a chance for selection of a less invasive and more appropriate surgical procedure, thus potentially improving the overall outcome. Therefore we consider that the data from the present case study add important information that would allow further preoperative diagnoses of AML in the future.
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[^1]: Abbreviations, HBsAg; hepatitis B virus surface antigen, HCVAb; hepatitis C virus antibody, AST: Aspartate Aminotransferase, ALT: alanine aminotransferase, γ-GTP: γ-glutamyl transpeptidase, ALP: alkaline phosphatase, T-Bil: total bilirubin, Alb; albumin, AFP; arfapheto protein, PIVKA II; vitamin K absence or antagonist- 2.
